C. Kuaban and . Vidal, Collaborators The EVOLCAM study group

G. Maradan, . Ambani, P. Ndalle, C. Momo, and . Tong,

S. Boyer, L. Boyer, . March, . Mora, . Sagaon-teyssier et al., , p.912

C. Laurent, . Liégeois, . Delaporte, E. Boyer, and . Duvernay, TransVIHMI

F. Chabrol, . Kouakam, . Ossanga, C. Essama-owona, M. Biloa et al., UCAC

N. E-mpoudi,

C. P-j-fouda, H. Kouanfack, . Abessolo, M. Noumssi, H. Defo et al.,

Z. Nanga, . Perfura, O. Ngo-tonye, . Kouambo, . Olinga et al.,

C. Ejangue, . Njom-nlend, and . Simo-ndongo,

N. E-abeng-mbozo'o,-m-mpoudi-ngole, C. Manga, . Danwe, . Ayangma, and . Taman,

E. Ndam, J. Fangam-molu, H. Meli, . Hadja, and . Lindou,

J. Oyono and S. Beke,

D. Eloundou and . Touko,

M. J-j-ze, . Fokoua, C. Ngum, C. Ewolo, and . Bondze,

J. Bilong, D. Maninzou, and . Nono-toche,

P. M-tsoungi-akoa, . Ateba, and . Abia, Mbalmayo

A. Guterrez and . Garcia, Bikop

Y. Belley-priso, . Mapoure, A. Malongue, B. Ndjong, . Mbatchou et al.,

J. Dissongo, I. Mbangue, H. Penda, G. Mossi, Y. Tchatchoua et al.,

M. Gomez, M. Mafuta, and . Mgantcha,

M. E-h-moby, A. Kuitcheu, and . Mawe, Ngam Engonwei (District Hospital

L. Bitang, M. Ndam, R. Pallawo, I. Adamou, and G. Temgoua, District Hospital

C. C-ndjie-essaga, . Tchimou, . Yeffou, H. Ngo, H. Fokam et al., District Hospital

S. L-r-njock, . Omgnesseck, . Kamto, and . Takou,

L. Buffeteau, F. Ndoumbe, J. Noah, and . Seyep,

A. Schweitzer, J. Horn, and R. T. Mikolajczyk, Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between, Lancet, vol.386, pp.1546-55, 1965.

J. Riou, A. Ahmed, M. Blake, and A. , Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis, J Viral Hepat, vol.23, pp.244-55, 2016.

M. Lemoine, S. Eholié, and K. Lacombe, Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach, J Hepatol, vol.62, pp.469-76, 2015.

J. Pépin and A. C. Labbé, Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses, Trop Med Int Health, vol.13, pp.744-53, 2008.

M. Lemoine and M. R. Thursz, Battlefield against hepatitis B infection and HCC in Africa, J Hepatol, vol.66, pp.645-54, 2017.

L. Breakwell, C. Tevi-benissan, and L. Childs, The status of hepatitis B control in the African region, Pan Afr Med J, vol.27, p.3, 2017.

, Guidelines on hepatitis B and C testing, 2017.

A. Dakar, Conférence internationale des acteurs de lutte contre les hépatites en Afrique francophone, 2011.

F. Chabrol, P. M. David, and G. Krikorian, Rationing hepatitis C treatment in the context of austerity policies in France and Cameroon: A transnational perspective on the pharmaceuticalization of healthcare systems, Soc Sci Med, vol.187, pp.243-50, 2017.

D. Pourette and C. Enel, Représentations et vécu de l'hépatite B de patients subsahariens en Côte d'Ivoire et en France, Santé Publique, vol.26, pp.869-78, 2014.

T. Giles-vernick, F. Hejoaka, and A. Sanou, Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa, Am J Trop Med Hyg, vol.95, pp.1368-75, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02548814

J. J. Bigna, M. A. Amougou, and S. L. Asangbeh, Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis, WHO. World health statistics, vol.7, p.15748, 2015.

R. Njouom, E. Nerrienet, and M. Dubois, The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960, Infect Genet Evol, vol.7, pp.361-368, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00542183

C. Tong, M. Suzan-monti, and L. Sagaon-teyssier, Treatment interruption in HIV-positive patients followed up in Cameroon's antiretroviral treatment programme: individual and health care supply-related factors (ANRS-12288 EVOLCam survey), Trop Med Int Health, vol.23, pp.315-341, 2018.

G. Foley and V. Timonen, Using Grounded Theory Method to Capture and Analyze Health Care Experiences, Health Serv Res, vol.50, pp.1195-210, 2015.

, The world health report 2000 -Health systems: improving performance, 1999.

K. Xu, D. B. Evans, and K. Kawabata, Household catastrophic health expenditure: a multicountry analysis, Lancet, vol.362, pp.111-118, 2003.

M. Subic and F. Zoulim, How to improve access to therapy in hepatitis B patients, Liver Int, vol.38, pp.115-136, 2018.

R. W. Peeling, D. I. Boeras, and F. Marinucci, The future of viral hepatitis testing: innovations in testing technologies and approaches, BMC Infect Dis, vol.17, p.699, 2017.

L. Duchesne and K. Lacombe, Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings, J Viral Hepat, vol.25, pp.108-125, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01651784

, Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection, 2017.

S. Boyer, F. Marcellin, and P. Ongolo-zogo, Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national crosssectional survey, Bull World Health Organ, vol.87, pp.279-87, 2009.

E. J. Mills, J. B. Nachega, and D. R. Bangsberg, Adherence to HAART: a systematic review of developed and developing nation patientreported barriers and facilitators, PLoS Med, vol.3, p.438, 2006.

S. Boyer, Cost-effectiveness of Sofosbuvir-Based Hepatitis C regimens in Central and West Africa (ANRS 12342). Oral presentation EASL conference, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02146894

, Progress report on access to hepatitis C treatment: WHO, 2018.

T. Galani, B. R. Njouom, R. Moundipa, and P. F. , Hepatitis C in Cameroon: What is the progress from 2001 to 2016?, J Transl Int Med, vol.4, pp.162-171, 2016.